TW200716650A - Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency - Google Patents
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potencyInfo
- Publication number
- TW200716650A TW200716650A TW095110760A TW95110760A TW200716650A TW 200716650 A TW200716650 A TW 200716650A TW 095110760 A TW095110760 A TW 095110760A TW 95110760 A TW95110760 A TW 95110760A TW 200716650 A TW200716650 A TW 200716650A
- Authority
- TW
- Taiwan
- Prior art keywords
- derivative
- thienopyridine
- quinoline
- quinazoline
- met autophosphorylation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005092881 | 2005-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200716650A true TW200716650A (en) | 2007-05-01 |
Family
ID=37053417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095110760A TW200716650A (en) | 2005-03-28 | 2006-03-28 | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090270391A1 (zh) |
| EP (1) | EP1870414A4 (zh) |
| JP (1) | JPWO2006104161A1 (zh) |
| KR (1) | KR20080007443A (zh) |
| CN (1) | CN101189241A (zh) |
| AU (1) | AU2006229343A1 (zh) |
| BR (1) | BRPI0608658A2 (zh) |
| CA (1) | CA2603125A1 (zh) |
| RU (1) | RU2007139785A (zh) |
| TW (1) | TW200716650A (zh) |
| WO (1) | WO2006104161A1 (zh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5096142B2 (ja) | 2004-07-30 | 2012-12-12 | メチルジーン インコーポレイテッド | Ｖｅｇｆレセプターおよびｈｇｆレセプターシグナル伝達の阻害剤 |
| BRPI0610382A2 (pt) * | 2005-05-20 | 2010-06-15 | Methylgene Inc | inibidores de sinalização de receptor de vegf e receptor de hgf |
| CN101796055B (zh) | 2005-05-20 | 2013-09-04 | 梅特希尔基因公司 | Vegf受体和hgf受体信号的抑制剂 |
| AR059246A1 (es) * | 2006-01-30 | 2008-03-19 | Array Biopharma Inc | Compuestos heterobiciclicos de tiofeno y metodos de uso |
| WO2007146824A2 (en) * | 2006-06-08 | 2007-12-21 | Array Biopharma Inc. | Quinoline compounds and methods of use |
| EP2426108B1 (en) | 2007-08-29 | 2016-08-10 | MethylGene Inc. | Processes and intermediates for preparing fused heterocyclic kinase inhibitors |
| WO2009026717A1 (en) * | 2007-08-29 | 2009-03-05 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
| TWI438205B (zh) | 2008-03-05 | 2014-05-21 | Methylgene Inc | 蛋白質酪胺酸激酶活性抑制劑 |
| MX2010011097A (es) * | 2008-04-10 | 2010-11-01 | Taiho Pharmaceutical Co Ltd | Compuesto de aciltiourea o sal del mismo, y uso del mismo. |
| AU2011241420B2 (en) * | 2010-04-16 | 2015-04-16 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
| EP2594566A4 (en) * | 2010-07-16 | 2014-10-01 | Kyowa Hakko Kirin Co Ltd | AROMATIC HETEROCYCLIC NITROGEN CYCLE DERIVATIVE |
| EP2522341A1 (en) * | 2011-05-13 | 2012-11-14 | Tragex Pharma | Pharmaceutical compositions comprising Neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| EP3583943A4 (en) | 2017-02-15 | 2020-12-30 | Taiho Pharmaceutical Co., Ltd. | PHARMACEUTICAL COMPOSITION |
| EP3942045A1 (en) | 2019-03-21 | 2022-01-26 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000194A2 (en) * | 2001-06-21 | 2003-01-03 | Pfizer Inc. | Thienopyridine and thienopyrimidine anticancer agents |
| DE60233736D1 (de) * | 2001-06-22 | 2009-10-29 | Kirin Pharma K K | Chinolinderivat und chinazolinderivat, die die selbstphosphorylierung des hepatocytus-proliferator-rezeptors hemmen, und diese enthaltende medizinische zusammensetzung |
| WO2005121125A1 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Inc. | Ether-linked heteroaryl compounds |
| US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7439246B2 (en) * | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
| JP5096142B2 (ja) * | 2004-07-30 | 2012-12-12 | メチルジーン インコーポレイテッド | Ｖｅｇｆレセプターおよびｈｇｆレセプターシグナル伝達の阻害剤 |
| BRPI0610382A2 (pt) * | 2005-05-20 | 2010-06-15 | Methylgene Inc | inibidores de sinalização de receptor de vegf e receptor de hgf |
| AR059246A1 (es) * | 2006-01-30 | 2008-03-19 | Array Biopharma Inc | Compuestos heterobiciclicos de tiofeno y metodos de uso |
-
2006
- 2006-03-27 AU AU2006229343A patent/AU2006229343A1/en not_active Abandoned
- 2006-03-28 WO PCT/JP2006/306334 patent/WO2006104161A1/ja active Application Filing
- 2006-03-28 BR BRPI0608658A patent/BRPI0608658A2/pt not_active IP Right Cessation
- 2006-03-28 EP EP06730282A patent/EP1870414A4/en not_active Withdrawn
- 2006-03-28 RU RU2007139785/04A patent/RU2007139785A/ru not_active Application Discontinuation
- 2006-03-28 US US11/910,078 patent/US20090270391A1/en not_active Abandoned
- 2006-03-28 KR KR1020077024794A patent/KR20080007443A/ko not_active Application Discontinuation
- 2006-03-28 CA CA002603125A patent/CA2603125A1/en not_active Abandoned
- 2006-03-28 TW TW095110760A patent/TW200716650A/zh unknown
- 2006-03-28 CN CNA2006800099025A patent/CN101189241A/zh active Pending
- 2006-03-28 JP JP2007510537A patent/JPWO2006104161A1/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006229343A1 (en) | 2006-10-05 |
| CA2603125A1 (en) | 2006-10-05 |
| RU2007139785A (ru) | 2009-05-10 |
| EP1870414A4 (en) | 2010-01-06 |
| CN101189241A (zh) | 2008-05-28 |
| BRPI0608658A2 (pt) | 2016-08-23 |
| US20090270391A1 (en) | 2009-10-29 |
| WO2006104161A1 (ja) | 2006-10-05 |
| EP1870414A1 (en) | 2007-12-26 |
| JPWO2006104161A1 (ja) | 2008-09-11 |
| KR20080007443A (ko) | 2008-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716650A (en) | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency | |
| MXPA05013349A (es) | Derivados de 2-amino-pirimidina como inhibidores de quinasa raf. | |
| ATE388958T1 (de) | 4'-c-substituierte 2-haloadenosinderivate | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| TW200732306A (en) | Pyrimidine derivatives | |
| HK1087632A1 (en) | 4-anilino-quinazoline derivatives as antiproliferative agents | |
| DK1382604T3 (da) | Quinolinderivater med en azolylgruppe og quinazolinderivater | |
| ZA200708159B (en) | 1-Acetic acid-indole derivatives with PDG2 antagonist activity | |
| TW200833675A (en) | Nicotinamide derivatives | |
| WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
| HK1069395A1 (en) | Phthalazinone derivatives 2,3 | |
| MY153393A (en) | Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors | |
| IL156873A0 (en) | Pharmaceutically active piperidine derivatives | |
| EA200800501A1 (ru) | Производные хинолина в качестве антибактериальных средств | |
| TW200637539A (en) | CTGF inhibitors | |
| EP1490371A4 (en) | TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS | |
| EP1854789A4 (en) | CHINAZOLINE DERIVATIVE WITH TYROSINE KINASE HEMMENDER EFFECT | |
| MX2009011769A (es) | Derivados de piridona como inhibidores de mapk p38a. | |
| TW200607808A (en) | Pyrido-pyrimidine derivatives, preparation thereof and application thereof | |
| TW200744589A (en) | Pharmaceutical composition | |
| MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
| DE60319080D1 (de) | Phenyloxyalkansäure-derivate als hppar aktivatore | |
| MXPA04008303A (es) | Inhibidores de la farnesil proteina transferasa como agentes antitumorales. | |
| TW200510384A (en) | Novel farnesyl protein transferase inhibitors as antitumor agents | |
| WO2009028387A1 (ja) | プロテアーゼ阻害剤耐性を有する癌の治療薬 |